Having demonstrated that IL-33 has a pro-survival role in AML samples by activating p38 and provoking IL-6 expression, we hypothesized that IL-33 may activate IL-6 expression in a manner that requires p38 MAPK activation. This evidence concerns the gene IL6 and acute myeloid leukemia.